d-alpha tocopherol has been researched along with Carcinoma, Ductal, Breast in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Colori, B; Di Bella, G; Toscano, R | 1 |
Erkisi, M; Kara, IO; Sahin, B | 1 |
Colomer, R; Lupu, R; Menéndez, JA; Ropero, S; Vázquez-Martín, A | 1 |
Buring, JE; Lin, J; Manson, JE; Selhub, J; Zhang, SM | 1 |
Appel, MJ; van Garderen-Hoetmer, A; Woutersen, RA | 1 |
Astre, C; Gerber, M; Grenier, J; Pujol, H; Saintot, M; Scali, J; Ségala, C; Simony-Lafontaine, J | 1 |
Heisler, T; McFadden, DW; Simon, N; Towfigh, S | 1 |
1 trial(s) available for d-alpha tocopherol and Carcinoma, Ductal, Breast
Article | Year |
---|---|
Plasma cysteinylglycine levels and breast cancer risk in women.
Topics: Alcohol Drinking; Breast Neoplasms; Carcinoma, Ductal, Breast; Case-Control Studies; Dipeptides; Female; Humans; Middle Aged; Obesity; Oxidative Stress; Peptide Fragments; Postmenopause; Prospective Studies; Receptors, Antigen, T-Cell; Risk Factors; Vitamin E | 2007 |
6 other study(ies) available for d-alpha tocopherol and Carcinoma, Ductal, Breast
Article | Year |
---|---|
Complete objective response, stable for 5 years, with the Di Bella Method, of multiple-metastatic carcinoma of the breast.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Female; Humans; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Retinoids; Treatment Outcome; Vitamin E | 2017 |
Palmar-plantar erythrodysesthesia due to docetaxel-capecitabine therapy is treated with vitamin E without dose reduction.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Deoxycytidine; Docetaxel; Erythema; Fatal Outcome; Female; Fluorouracil; Foot; Hand; Humans; Middle Aged; Paresthesia; Taxoids; Vitamin E | 2006 |
HER2 (erbB-2)-targeted effects of the omega-3 polyunsaturated fatty acid, alpha-linolenic acid (ALA; 18:3n-3), in breast cancer cells: the "fat features" of the "Mediterranean diet" as an "anti-HER2 cocktail".
Topics: alpha-Linolenic Acid; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Diet, Mediterranean; Dietary Fats, Unsaturated; Down-Regulation; Drug Synergism; Enzyme Induction; Enzyme-Linked Immunosorbent Assay; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Female; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Gene Amplification; Genes, erbB-2; Humans; Neoplasm Proteins; Promoter Regions, Genetic; Receptor, ErbB-2; Reverse Transcriptase Polymerase Chain Reaction; Trastuzumab; Vitamin E | 2006 |
Lack of inhibitory effects of beta-carotene, vitamin C, vitamin E and selenium on development of ductular adenocarcinomas in exocrine pancreas of hamsters.
Topics: Adenocarcinoma; Animals; Ascorbic Acid; beta Carotene; Body Weight; Carcinogens; Carcinoma, Ductal, Breast; Carotenoids; Cricetinae; Diet; Male; Mesocricetus; Nitrosamines; Organ Size; Pancreatic Neoplasms; Selenium; Vitamin E | 1996 |
Tumor progression and oxidant-antioxidant status.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Carcinoma in Situ; Carcinoma, Ductal, Breast; Case-Control Studies; Cholesterol; Female; Humans; Male; Malondialdehyde; Middle Aged; Neoplasms; Sex Factors; Vitamin E | 1997 |
Peptide YY and vitamin E inhibit hormone-sensitive and -insensitive breast cancer cells.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Cell Survival; Coloring Agents; Female; Humans; Peptide YY; Receptors, Estrogen; Tetrazolium Salts; Thiazoles; Tocopherols; Tumor Cells, Cultured; Vitamin E | 2000 |